Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis

INTRODUCTION: Idiopathic pulmonary fibrosis is a progressive diffuse parenchymal lung disorder of unknown etiology. Mesenchymal stem cell (MSC)-based therapy is a novel approach with great therapeutic potential for the treatment of lung diseases. Despite demonstration of MSC grafting, the population...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Ying-Wei, Choo, Kong-Bung, Chen, Chuan-Mu, Hung, Tsai-Hsien, Chen, Young-Bin, Hsieh, Chung-Hsing, Kuo, Han-Pin, Chong, Kowit-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487587/
https://www.ncbi.nlm.nih.gov/pubmed/25986930
http://dx.doi.org/10.1186/s13287-015-0081-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487587/
https://www.ncbi.nlm.nih.gov/pubmed/25986930
http://dx.doi.org/10.1186/s13287-015-0081-6

Ejemplares similares